13 Jun, 2012 20:54 CET
-
Dian Griesel Inc
Full details of the work are published today in the journal Science Translational Medicine. The paper covers findings from the U.K. translational clinical trial (REO 013) investigating the cancer drug, REOLYSIN (Oncolytics Biotech) in patients with metastatic colorectal cancer prior to surgical resection of liver metastases.
Scientists have shown how a promising viral therapy that delivers a double blow to...